REGENXBIO (RGNX) Earnings Date, Estimates & Call Transcripts $8.24 -0.46 (-5.29%) Closing price 04:00 PM EasternExtended Trading$8.24 +0.00 (+0.06%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock REGENXBIO Earnings Summary REGENXBIO posted Q1 2025 earnings on May 12, 2025, reporting an EPS of $0.12, which missed analysts' consensus estimates of $0.41 by $0.29. Quarterly revenue was reported to be $89.01 million, below the consensus estimate of $105.35 million. With a trailing EPS of -$3.11, REGENXBIO's earnings are expected to grow next year, from ($4.84) to ($1.25) per share. Upcoming Q2 Earnings DateAug. 7After Market ClosesEstimatedConsensus EPS (May. 12) $0.41 Actual EPS (May. 12) $0.12 Missed By -$0.29 Actual Revenue (May. 12) $89.01MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)RGNX Upcoming EarningsREGENXBIO's Q2 2025 earnings is scheduled for Thursday, August 7, 2025, with a conference call scheduled on Tuesday, August 5, 2025 at 12:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get REGENXBIO Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on REGENXBIO and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRGNX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RGNX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. REGENXBIO Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.21$0.65-$0.28Q2 20252-$1.17-$0.89-$1.03Q3 20252-$1.17$2.60$0.72Q4 20252-$1.48-$1.16-$1.32 FY 2025 8 -$5.03 $1.20 -$1.92 Q1 20261-$1.16-$1.16-$1.16Q2 20261-$1.15-$1.15-$1.15Q3 20261-$0.56-$0.56-$0.56Q4 20261-$0.51-$0.51-$0.51 REGENXBIO Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/7/2025(Estimated)--------5/12/2025Q1 2025$0.41$0.12 -$0.29$0.12$105.35M$89.01M3/13/2025Q4 2024-$1.27-$1.01+$0.26-$1.01$23.70M$21.21M8/1/2024Q2 2024-$1.29-$1.05+$0.24-$1.05$22.97M$22.30M5/8/2024Q1 2024-$1.28-$1.38 -$0.10-$1.38$23.52M$15.60M2/27/2024Q4 2023-$1.27-$1.43 -$0.16-$1.43$34.01M$22.30M11/8/2023Q3 2023-$1.44-$1.41+$0.03-$1.41$26.14M$28.90M8/2/2023Q2 2023-$1.26-$1.66 -$0.40-$1.66$34.50M$19.98M REGENXBIO Earnings - Frequently Asked Questions When is REGENXBIO's earnings date? REGENXBIO has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 7th, 2025 based off last year's report dates. Learn more on RGNX's earnings history. Did REGENXBIO beat their earnings estimates last quarter? In the previous quarter, REGENXBIO (NASDAQ:RGNX) missed the analysts' consensus estimate of $0.41 by $0.29 with a reported earnings per share (EPS) of $0.12. Learn more on analysts' earnings estimate vs. RGNX's actual earnings. How can I listen to REGENXBIO's earnings conference call? The conference call for REGENXBIO's latest earnings report can be listened to online. Listen to Conference Call How can I read REGENXBIO's conference call transcript? The conference call transcript for REGENXBIO's latest earnings report can be read online. Read Transcript How much revenue does REGENXBIO generate each year? REGENXBIO (NASDAQ:RGNX) has a recorded annual revenue of $156.72 million. How much profit does REGENXBIO generate each year? REGENXBIO (NASDAQ:RGNX) has a recorded net income of -$227.10 million. RGNX has generated -$3.11 earnings per share over the last four quarters. What is REGENXBIO's EPS forecast for next year? REGENXBIO's earnings are expected to grow from ($4.84) per share to ($1.25) per share in the next year. More Earnings Resources from MarketBeat Related Companies SPRY Earnings TARS Earnings IMCR Earnings ARQT Earnings OCUL Earnings SDGR Earnings ETNB Earnings VERA Earnings JANX Earnings BHVN Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:RGNX) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share REGENXBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
